Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease
Authors:
Open Access
- 24 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (3) , 620
Abstract
Sir, We read Koduri et al.’s [1] article with great interest. Since publishing our original study [2] we now have a 13- to 15-year follow-up on RA patients with interstitial lung disease (ILD) diagnosed by high-resolution CT (HRCT). As the paper looked at prognosis, we decided to evaluate our own data, looking at death as an outcome. The study had ethical approval from St Helens and Knowsley Research Ethics Committee for the original study and follow-up. We used the Goh et al. HRCT scoring system [3] that has been evaluated in scleroderma. The initial ILD has been converted from the Wells HRCT ILD scoring system [4] to the Goh et al. system as limited (0–20%), borderline (20–25%) or extensive (>25%) involvement.Keywords
This publication has 5 references indexed in Scilit:
- Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohortRheumatology, 2010
- Interstitial Lung Disease in Systemic SclerosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumoniaArthritis & Rheumatism, 2005
- Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2002
- Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.American Journal of Roentgenology, 1993